Life Sciences 2019

Last Updated: 12 April 2019

Life Sciences 2019 - Comparisons

  • {{chapter}}
Last Updated: 12 April 2019

Contributors:
Van Bael & Bellis
(Law and Practice)


Choose topics
( )

Table of contents

SECTION: Law and Practice (by Van Bael & Bellis)

Contributors:
Van Bael & Bellis
(Law and Practice)


About the contributors:
Van Bael & Bellis

has one of the leading life sciences practices in Brussels, covering the full range of services in the life sciences field, including EU and Belgian advice on regulatory, marketing and advertising, intellectual property and competition law matters as well as representation and advocacy before ... various judicial and administrative bodies and industry boards. The team works with some of the world’s largest pharmaceutical, biotechnology and medical devices companies, regularly advising and training them on a range of issues that healthcare companies might be faced with, including but not limited to registration matters, early market access schemes, pricing and reimbursement, pre- and post-marketing regulatory issues, clinical trials, public procurement, compliance investigations, data exclusivity, community referral procedures, variations, orphan medicines, advanced therapies, life cycle management issues, product recalls, distribution agreements, reporting of Transfers of Value, etc. In the pharmaceutical area, the team advises manufacturers of medicines for human use as well as for veterinary use. We would like to thank Melody Moodley, Margot Vogels and Simón Hernández for their contribution to this article.